Global Cancer mTOR Inhibitors Market Data Survey Report 2015-2025
- HEY3425315
- 69 Pages
- January 2020
- Healthcare
The global Cancer mTOR Inhibitors market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major End-Use
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
Abraxis BioScience
Adimab
Celgene Corporation
Celator Pharmaceuticals
Eli Lilly
Exelixis
GlaxoSmithKline
HEC Pharm
Intellikine
Novartis
Oneness Biotech
PIQUR Therapeutics
Semafore Pharmaceuticals
Takeda
Wyeth
Major applications as follows:
Breast Cancer
Hematological Malignancy
Neuroendocrine Tumors
Hepatocellular Carcinoma
Glioblastoma
Major Type as follows:
Afinitor/Votubia
Afinitor Disperz andndash; mTOR inhibitor for Rare Pediatric Brain Tumor
Torisel (Temsirolimus)
Evertor andndash
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of End-Use
1.1.4 Scope of Product Type
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
Fig Global Cancer mTOR Inhibitors Market Size and CAGR 2015-2019 (Million USD)
Fig Global Cancer mTOR Inhibitors Market Size and CAGR 2015-2019 (Volume)
Fig Global Cancer mTOR Inhibitors Market Forecast and CAGR 2020-2025 (Million USD)
Fig Global Cancer mTOR Inhibitors Market Forecast and CAGR 2020-2025 (Volume)
2 Regional Market
2.1 Regional Sales
Tab Regional Sales Revenue 2015-2019 (Million USD)
Tab Regional Sales Volume 2015-2019 (Volume)
2.2 Regional Demand
Tab Regional Demand and CAGR List 2015-2019 (Million USD)
Tab Regional Demand and CAGR List 2015-2019 (Volume)
Tab Regional Demand Forecast and CAGR 2020-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2020-2025 (Volume)
2.3 Regional Trade
Tab Regional Export 2015-2019 (Million USD)
Tab Regional Export 2015-2019 (Volume)
Tab Regional Import 2015-2019 (Million USD)
Tab Regional Import 2015-2019 (Volume)
3 Key Manufacturers
3.1 Abraxis BioScience
3.1.1 Company Information
Tab Company Profile List of Abraxis BioScience
3.1.2 Product & Services
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Abraxis BioScience
3.1.4 Recent Development
3.2 Adimab
3.2.1 Company Information
Tab Company Profile List of Adimab
3.2.2 Product & Services
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Adimab
3.2.4 Recent Development
3.3 Celgene Corporation
3.3.1 Company Information
Tab Company Profile List of Celgene Corporation
3.3.2 Product & Services
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Celgene Corporation
3.3.4 Recent Development
3.4 Celator Pharmaceuticals
3.4.1 Company Information
Tab Company Profile List of Celator Pharmaceuticals
3.4.2 Product & Services
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Celator Pharmaceuticals
3.4.4 Recent Development
3.5 Eli Lilly
3.5.1 Company Information
Tab Company Profile List of Eli Lilly
3.5.2 Product & Services
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Eli Lilly
3.5.4 Recent Development
3.6 Exelixis
3.6.1 Company Information
Tab Company Profile List of Exelixis
3.6.2 Product & Services
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Exelixis
3.6.4 Recent Development
3.7 GlaxoSmithKline
3.7.1 Company Information
Tab Company Profile List of GlaxoSmithKline
3.7.2 Product & Services
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of GlaxoSmithKline
3.7.4 Recent Development
3.8 HEC Pharm
3.8.1 Company Information
Tab Company Profile List of HEC Pharm
3.8.2 Product & Services
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of HEC Pharm
3.8.4 Recent Development
3.9 Intellikine
3.9.1 Company Information
Tab Company Profile List of Intellikine
3.9.2 Product & Services
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Intellikine
3.9.4 Recent Development
3.10 Novartis
3.10.1 Company Information
Tab Company Profile List of Novartis
3.10.2 Product & Services
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Novartis
3.10.4 Recent Development
3.11 Oneness Biotech
3.11.1 Company Information
Tab Company Profile List of Oneness Biotech
3.11.2 Product & Services
3.11.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Oneness Biotech
3.11.4 Recent Development
3.12 PIQUR Therapeutics
3.12.1 Company Information
Tab Company Profile List of PIQUR Therapeutics
3.12.2 Product & Services
3.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of PIQUR Therapeutics
3.12.4 Recent Development
3.13 Semafore Pharmaceuticals
3.13.1 Company Information
Tab Company Profile List of Semafore Pharmaceuticals
3.13.2 Product & Services
3.13.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Semafore Pharmaceuticals
3.13.4 Recent Development
3.14 Takeda
3.14.1 Company Information
Tab Company Profile List of Takeda
3.14.2 Product & Services
3.14.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Takeda
3.15 Wyeth
3.15.1 Company Information
Tab Company Profile List of Wyeth
3.15.2 Product & Services
3.15.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Wyeth
4 Major End-Use
4.1 Breast Cancer
4.1.1 Overview
Tab Summary of Consumption Distribution of Breast Cancer
4.1.2 Breast Cancer Market Size and Forecast
Fig Breast Cancer Market Size and CAGR 2015-2019 (Million USD)
Fig Breast Cancer Market Size and CAGR 2015-2019 (Volume)
Fig Breast Cancer Market Forecast and CAGR 2020-2025 (Million USD)
Fig Breast Cancer Market Forecast and CAGR 2020-2025 (Volume)
4.2 Hematological Malignancy
4.2.1 Overview
Tab Summary of Consumption Distribution of Hematological Malignancy
4.2.2 Hematological Malignancy Market Size and Forecast
Fig Hematological Malignancy Market Size and CAGR 2015-2019 (Million USD)
Fig Hematological Malignancy Market Size and CAGR 2015-2019 (Volume)
Fig Hematological Malignancy Market Forecast and CAGR 2020-2025 (Million USD)
Fig Hematological Malignancy Market Forecast and CAGR 2020-2025 (Volume)
4.3 Neuroendocrine Tumors
4.3.1 Overview
Tab Summary of Consumption Distribution of Neuroendocrine Tumors
4.3.2 Neuroendocrine Tumors Market Size and Forecast
Fig Neuroendocrine Tumors Market Size and CAGR 2015-2019 (Million USD)
Fig Neuroendocrine Tumors Market Size and CAGR 2015-2019 (Volume)
Fig Neuroendocrine Tumors Market Forecast and CAGR 2020-2025 (Million USD)
Fig Neuroendocrine Tumors Market Forecast and CAGR 2020-2025 (Volume)
4.4 Hepatocellular Carcinoma
4.4.1 Overview
Tab Summary of Consumption Distribution of Hepatocellular Carcinoma
4.4.2 Hepatocellular Carcinoma Market Size and Forecast
Fig Hepatocellular Carcinoma Market Size and CAGR 2015-2019 (Million USD)
Fig Hepatocellular Carcinoma Market Size and CAGR 2015-2019 (Volume)
Fig Hepatocellular Carcinoma Market Forecast and CAGR 2020-2025 (Million USD)
Fig Hepatocellular Carcinoma Market Forecast and CAGR 2020-2025 (Volume)
4.5 Glioblastoma
4.5.1 Overview
Tab Summary of Consumption Distribution of Glioblastoma
4.5.2 Glioblastoma Market Size and Forecast
Fig Glioblastoma Market Size and CAGR 2015-2019 (Million USD)
Fig Glioblastoma Market Size and CAGR 2015-2019 (Volume)
Fig Glioblastoma Market Forecast and CAGR 2020-2025 (Million USD)
Fig Glioblastoma Market Forecast and CAGR 2020-2025 (Volume)
5 Market by Type
5.1 Afinitor/Votubia
5.1.1 Overview
Tab Product Overview of Afinitor/Votubia
5.1.2 Afinitor/Votubia Market Size and Forecast
Fig Afinitor/Votubia Market Size and CAGR 2015-2019 (Million USD)
Fig Afinitor/Votubia Market Size and CAGR 2015-2019 (Volume)
Fig Afinitor/Votubia Market Forecast and CAGR 2020-2025 (Million USD)
Fig Afinitor/Votubia Market Forecast and CAGR 2020-2025 (Volume)
5.2 Afinitor Disperz andndash; mTOR inhibitor for Rare Pediatric Brain Tumor
5.2.1 Overview
Tab Product Overview of Afinitor Disperz andndash; mTOR inhibitor for Rare Pediatric Brain Tumor
5.2.2 Afinitor Disperz andndash; mTOR inhibitor for Rare Pediatric Brain Tumor Market Size and Forecast
Fig Afinitor Disperz andndash; mTOR inhibitor for Rare Pediatric Brain Tumor Market Size and CAGR 2015-2019 (Million USD)
Fig Afinitor Disperz andndash; mTOR inhibitor for Rare Pediatric Brain Tumor Market Size and CAGR 2015-2019 (Volume)
Fig Afinitor Disperz andndash; mTOR inhibitor for Rare Pediatric Brain Tumor Market Forecast and CAGR 2020-2025 (Million USD)
Fig Afinitor Disperz andndash; mTOR inhibitor for Rare Pediatric Brain Tumor Market Forecast and CAGR 2020-2025 (Volume)
5.3 Torisel (Temsirolimus)
5.3.1 Overview
Tab Product Overview of Torisel (Temsirolimus)
5.3.2 Torisel (Temsirolimus) Market Size and Forecast
Fig Torisel (Temsirolimus) Market Size and CAGR 2015-2019 (Million USD)
Fig Torisel (Temsirolimus) Market Size and CAGR 2015-2019 (Volume)
Fig Torisel (Temsirolimus) Market Forecast and CAGR 2020-2025 (Million USD)
Fig Torisel (Temsirolimus) Market Forecast and CAGR 2020-2025 (Volume)
5.4 Evertor andndash
5.4.1 Overview
Tab Product Overview of Evertor andndash
5.4.2 Evertor andndash Market Size and Forecast
Fig Evertor andndash Market Size and CAGR 2015-2019 (Million USD)
Fig Evertor andndash Market Size and CAGR 2015-2019 (Volume)
Fig Evertor andndash Market Forecast and CAGR 2020-2025 (Million USD)
Fig Evertor andndash Market Forecast and CAGR 2020-2025 (Volume)
6 Price Overview
6.1 Price by Manufacturers
Tab Different Products Prices List of Major Manufacturers
6.2 Price by End-Use
Tab Different Products Prices List of End-Use
6.3 Price by Type
Tab Different Products Prices List of Produt Type
7 Conclusion
Tab Regional Sales Revenue 2015-2019 (Million USD)
Tab Regional Sales Volume 2015-2019 (Volume)
Tab Regional Demand and CAGR List 2015-2019 (Million USD)
Tab Regional Demand and CAGR List 2015-2019 (Volume)
Tab Regional Demand Forecast and CAGR 2020-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2020-2025 (Volume)
Tab Regional Export 2015-2019 (Million USD)
Tab Regional Export 2015-2019 (Volume)
Tab Regional Import 2015-2019 (Million USD)
Tab Regional Import 2015-2019 (Volume)
Tab Company Profile List of Abraxis BioScience
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Abraxis BioScience
Tab Company Profile List of Adimab
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Adimab
Tab Company Profile List of Celgene Corporation
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Celgene Corporation
Tab Company Profile List of Celator Pharmaceuticals
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Celator Pharmaceuticals
Tab Company Profile List of Eli Lilly
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Eli Lilly
Tab Company Profile List of Exelixis
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Exelixis
Tab Company Profile List of GlaxoSmithKline
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of GlaxoSmithKline
Tab Company Profile List of HEC Pharm
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of HEC Pharm
Tab Company Profile List of Intellikine
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Intellikine
Tab Company Profile List of Novartis
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Novartis
Tab Company Profile List of Oneness Biotech
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Oneness Biotech
Tab Company Profile List of PIQUR Therapeutics
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of PIQUR Therapeutics
Tab Company Profile List of Semafore Pharmaceuticals
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Semafore Pharmaceuticals
Tab Company Profile List of Takeda
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Takeda
Tab Company Profile List of Wyeth
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Wyeth
Tab Summary of Consumption Distribution of Breast Cancer
Tab Summary of Consumption Distribution of Hematological Malignancy
Tab Summary of Consumption Distribution of Neuroendocrine Tumors
Tab Summary of Consumption Distribution of Hepatocellular Carcinoma
Tab Summary of Consumption Distribution of Glioblastoma
Tab Product Overview of Afinitor/Votubia
Tab Product Overview of Afinitor Disperz andndash; mTOR inhibitor for Rare Pediatric Brain Tumor
Tab Product Overview of Torisel (Temsirolimus)
Tab Product Overview of Evertor andndash
Tab Different Products Prices List of Major Manufacturers
Tab Different Products Prices List of End-Use
Tab Different Products Prices List of Produt Type
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
